Petty RE, Southwood TR, Manners P, et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol. 2004;31(2):390–2.

PubMed  Google Scholar 

Petty RE, Laxer RM, Lindsley CB, Wedderburn LR, Mellins ED, Fuhlbrigge RC, editors. Textbook of pediatric rheumatology. 8th ed. Philadelphia: Elsevier; 2021.

Google Scholar 

Guzman J, Oen K, Huber AM, et al. The risk and nature of flares in juvenile idiopathic arthritis: results from the ReACCh-Out cohort. Ann Rheum Dis. 2016;75(6):1092–8. https://doi.org/10.1136/annrheumdis-2014-207164.

Article  PubMed  Google Scholar 

Packham JC, Hall MA. Long‐term follow‐up of 246 adults with juvenile idiopathic arthritis: functional outcome. Rheumatology. 2002;41(12):1428–35. https://doi.org/10.1093/rheumatology/41.12.1428.

Article  CAS  PubMed  Google Scholar 

Oen K, Malleson PN, Cabral DA, Rosenberg AM, Petty RE, Cheang M. Disease course and outcome of juvenile rheumatoid arthritis in a multicenter cohort. J Rheumatol. 2002;29(9):1989–99.

PubMed  Google Scholar 

Brunner HI, Schanberg LE, Kimura Y, et al. New medications are needed for children with juvenile idiopathic arthritis. Arthritis Rheumatol. 2020;72(11):1945–51. https://doi.org/10.1002/art.41390.

Article  PubMed  PubMed Central  Google Scholar 

Ringold S, Weiss PF, Colbert RA, et al. Childhood Arthritis and Rheumatology Research Alliance consensus treatment plans for new-onset polyarticular juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2014;66(7):1063–72. https://doi.org/10.1002/acr.22259.

Article  PubMed  PubMed Central  Google Scholar 

Bathon JM, Martin RW, Fleischmann RM, et al. A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med. 2000;343(22):1586–93. https://doi.org/10.1056/NEJM200011303432201.

Article  CAS  PubMed  Google Scholar 

Landewé RBM, Boers M, Verhoeven AC, et al. COBRA combination therapy in patients with early rheumatoid arthritis: long-term structural benefits of a brief intervention. Arthritis Rheum. 2002;46(2):347–56. https://doi.org/10.1002/art.10083.

Article  CAS  PubMed  Google Scholar 

Genovese MC, Bathon JM, Martin RW, et al. Etanercept versus methotrexate in patients with early rheumatoid arthritis: two-year radiographic and clinical outcomes. Arthritis Rheum. 2002;46(6):1443–50. https://doi.org/10.1002/art.10308.

Article  CAS  PubMed  Google Scholar 

Goekoop-Ruiterman YPM, de Vries-Bouwstra JK, Allaart CF, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum. 2005;52(11):3381–90. https://doi.org/10.1002/art.21405.

Article  CAS  PubMed  Google Scholar 

Mease PJ, Gladman DD, Collier DH, et al. Etanercept and methotrexate as monotherapy or in combination for psoriatic arthritis: primary results from a randomized, controlled phase III trial. Arthritis Rheumatol. 2019;71(7):1112–24. https://doi.org/10.1002/art.40851.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nigrovic PA, Colbert RA, Holers VM, et al. Biological classification of childhood arthritis: roadmap to a molecular nomenclature. Nat Rev Rheumatol. 2021;17(5):257–69. https://doi.org/10.1038/s41584-021-00590-6.

Article  PubMed  PubMed Central  Google Scholar 

Nigrovic PA. Review: is there a window of opportunity for treatment of systemic juvenile idiopathic arthritis? Arthritis Rheumatol. 2014;66(6):1405–13. https://doi.org/10.1002/art.38615.

Article  CAS  PubMed  Google Scholar 

Beukelman T, Tomlinson G, Nigrovic PA, et al. First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans. Pediatr Rheumatol Online J. 2022;20:113. https://doi.org/10.1186/s12969-022-00768-6.

Article  PubMed  PubMed Central  Google Scholar 

Vastert SJ, de Jager W, Noordman BJ, et al. Effectiveness of first-line treatment with recombinant interleukin-1 receptor antagonist in steroid-naive patients with new-onset systemic juvenile idiopathic arthritis: results of a prospective cohort study. Arthritis Rheumatol. 2014;66(4):1034–43. https://doi.org/10.1002/art.38296.

Article  CAS  PubMed  Google Scholar 

Tynjälä P, Vähäsalo P, Tarkiainen M, et al. Aggressive combination drug therapy in very early polyarticular juvenile idiopathic arthritis (ACUTE-JIA): a multicentre randomised open-label clinical trial. Ann Rheum Dis. 2011;70(9):1605–12. https://doi.org/10.1136/ard.2010.143347.

Article  CAS  PubMed  Google Scholar 

Wallace CA, Giannini EH, Spalding SJ, et al. Trial of early aggressive therapy in polyarticular juvenile idiopathic arthritis. Arthritis Rheum. 2012;64(6):2012–21. https://doi.org/10.1002/art.34343.

Article  PubMed  Google Scholar 

Wallace CA, Giannini EH, Spalding SJ, et al. Clinically inactive disease in a cohort of children with new-onset polyarticular juvenile idiopathic arthritis treated with early aggressive therapy: time to achievement, total duration, and predictors. J Rheumatol. 2014;41(6):1163–70. https://doi.org/10.3899/jrheum.131503.

Article  PubMed  Google Scholar 

Kimura Y, Schanberg LE, Tomlinson GA, et al. Optimizing the start time of biologics in polyarticular juvenile idiopathic arthritis: a comparative effectiveness study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans. Arthritis Rheumatol. 2021;73(10):1898–909. https://doi.org/10.1002/art.41888.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ringold S, Ong MS, Tomlinson G, et al. Three-year outcomes and latent class trajectory analysis of the Childhood Arthritis and Rheumatology Research Alliance Polyarticular JIA Consensus Treatment Plans study. Arthritis Rheumatol. 2025. https://doi.org/10.1002/art.43216.

Article  PubMed  Google Scholar 

Wallace CA, Giannini EH, Huang B, et al. American College of Rheumatology provisional criteria for defining clinical inactive disease in select categories of juvenile idiopathic arthritis. Arthritis Care Res (Hoboken). 2011;63(7):929–36. https://doi.org/10.1002/acr.20497.

Article  PubMed  Google Scholar 

Trincianti C, Van Dijkhuizen EHP, Alongi A, et al. Definition and validation of the American College of Rheumatology 2021 Juvenile Arthritis Disease Activity Score cutoffs for disease activity states in juvenile idiopathic arthritis. Arthritis Rheumatol. 2021;73(11):1966–75. https://doi.org/10.1002/art.41879.

Article  PubMed  PubMed Central  Google Scholar 

de Jonge JB, de Roock S, Schonenberg-Meinema D, et al. Effect of time to start of biologic therapy on treatment response in childhood arthritis: results from the UCAN CAN-DU study. Arthritis Rheumatol. 2025. https://doi.org/10.1002/art.43401.

Huang B, Qiu T, Chen C, et al. Timing matters: real-world effectiveness of early combination of biologic and conventional synthetic disease-modifying antirheumatic drugs for treating newly diagnosed polyarticular course juvenile idiopathic arthritis. RMD Open. 2020;6(1):e001091. https://doi.org/10.1136/rmdopen-2019-001091.

Article  PubMed  PubMed Central  Google Scholar 

Giannini EH, Ruperto N, Ravelli A, Lovell DJ, Felson DT, Martini A. Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum. 1997;40(7):1202–9. https://doi.org/10.1002/1529-0131(199707)40:7<1202::AID-ART3>3.0.CO;2-R.

Article  CAS  PubMed  Google Scholar 

Alexeeva E, Horneff G, Dvoryakovskaya T, et al. Early combination therapy with etanercept and methotrexate in JIA patients shortens the time to reach an inactive disease state and remission: results of a double-blind placebo-controlled trial. Pediatr Rheumatol. 2021;19(1):5. https://doi.org/10.1186/s12969-020-00488-9.

Article  Google Scholar 

Lovell DJ, Johnson AL, Huang B, et al. Risk, timing, and predictors of disease flare after discontinuation of anti-tumor necrosis factor therapy in children with polyarticular forms of juvenile idiopathic arthritis with clinically inactive disease. Arthritis Rheumatol. 2018;70(9):1508–18. https://doi.org/10.1002/art.40509.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Burrone M, Mazzoni M, Naddei R, et al. Looking for the best strategy to treat children with new onset juvenile idiopathic arthritis: presentation of the “comparison of STep-up and step-down therapeutic strategies in childhood ARthritiS” (STARS) trial. Pediatr Rheumatol Online J. 2022;20(1):80. https://doi.org/10.1186/s12969-022-00739-x.

Article  PubMed  PubMed Central  Google Scholar 

Ringold S, Angeles-Han ST, Beukelman T, et al. 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Treatment of Juvenile Idiopathic Arthritis: therapeutic approaches for non-systemic polyarthritis, sacroiliitis, and enthesitis. Arthriti